Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
Stage-specific digital health technology biomarkers enhance diagnostic and early progression detection in Parkinson's disease.
Journal: Frontiers in neurology
Published: April 30, 2026
Fixed-Dose Tavapadon for Early Parkinson Disease: A Randomized Clinical Trial.
Journal: JAMA neurology
Published: March 20, 2026
Tavapadon as Adjunctive Treatment for Parkinson Disease: The TEMPO-3 Randomized Clinical Trial.
Journal: JAMA neurology
Published: March 20, 2026
Mass balance study of [14C]-ABBV-552, a synaptic vesicle glycoprotein 2A positive modulator, in healthy male participants following single oral dose administration.
Journal: European journal of clinical pharmacology
Published: January 20, 2026
Comparison of ABBV-552 Safety and Pharmacokinetics in Healthy Asian and Western Adults.
Journal: Clinical pharmacology in drug development
Published: December 19, 2025
Safety, tolerability, and efficacy of flexible-dose tavapadon for Parkinson's disease (TEMPO-2): a phase 3, randomised, placebo-controlled, double-blind trial.
Journal: The Lancet. Neurology
Published: November 06, 2025
Five-Year Outcomes from Deep Brain Stimulation of the Subthalamic Nucleus for Parkinson Disease.
Journal: JAMA neurology
Published: September 15, 2025
ABBV-552 in patients with mild Alzheimer's disease: a randomized phase IIb trial.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: September 10, 2025
Safety, Tolerability, and Pharmacokinetics of Single Doses of Exidavnemab (BAN0805), an Anti-α-Synuclein Antibody, in Healthy Western, Caucasian, Japanese, and Han Chinese Adults.
Journal: Journal of clinical pharmacology
Published: April 12, 2024
Predictors of Cognitive Change in Parkinson Disease: A 2-year Follow-up Study.
Journal: Alzheimer disease and associated disorders
Published: February 05, 2023
Comparative Effectiveness of Device-Aided Therapies on Quality of Life and Off-Time in Advanced Parkinson's Disease: A Systematic Review and Bayesian Network Meta-analysis.
Journal: CNS drugs
Published: September 29, 2022
Effects of Levodopa-Carbidopa Intestinal Gel on Dyskinesia and Non-Motor Symptoms Including Sleep: Results from a Meta-Analysis with 24-Month Follow-Up.
Journal: Journal of Parkinson's disease
Published: August 14, 2022
Last Updated: 09/26/2026